Aprogen Medicines Inc.

Research Aprogen Medicines Inc. (007460.KS) on Bullrun: market cap KRW 43.82B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 43.82B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-16KRW 43.82Bn/an/an/a

Dividend history

About Aprogen Medicines Inc.

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs.

Related stock research

South Korea stocks South Korea Industrials stocks A-Z stock index

Other Industrials stocks

SK Inc. (034730) KPX Holdings Co., Ltd. (092230.KS) Samsung SDI Co., Ltd. (006400) HMM Co.,Ltd (011200) Hy-Lok Corporation (013030.KQ) Samsung C&T Corporation (028260) Hyundai Everdigm Corp. (041440.KQ) Korea Electronic Certification Authority, Inc. (041460.KQ) Vitzro Tech Co. Ltd (042370.KQ) Haisung Aero-Robotics Co., Ltd. (059270.KQ) Trinity Airways Co., Ltd. (091810.KS) Kishin Corporation (092440.KS)

Frequently asked questions

What is Aprogen Medicines Inc.'s market cap?

Aprogen Medicines Inc.'s market capitalization is KRW 43.82B.

What does Aprogen Medicines Inc. do?

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs.